Niall Browne

Niall Browne

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GLGillian M. Lavelle
Gillian M. Lavelle
MWMichelle M. White
Michelle M. White
NBNiall Browne
Niall Browne
NMNoel G. McElvaney
Noel G. McElvaney
EREmer Reeves
Emer Reeves
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The resultant characteristic ion transport defect results in decreased mucociliary clearance, bacterial colonisation, and chronic neutrophil-dominated inflammation. Much knowledge surrounding the pathophysiology of the disease has been gained through the generation of animal models, despite inherent limitations in each. The failure of certain mouse models to recapitulate the phenotypic manifestations of human disease has initiated the generation of larger animals in which to study CF, including the pig and the ferret. This review will summarise the basic phenotypes of three animal models and describe the contributions of such animal studies to our current understanding of CF.

1 September 2018 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
GRGarret Rochford
Garret Rochford
ZMZara Molphy
Zara Molphy
NBNiall Browne
Niall Browne
CSCarla Surlis
Carla Surlis
MDMichael Devereux
Michael Devereux
KKKevin Kavanagh
Kevin Kavanagh

18 June 2019 in Journal of Applied Animal Nutrition
Verified
Journal Article
Closed access
PDF file
NBNiall Browne
Niall Browne
ATAimee Traynor
Aimee Traynor
KHKarina A. Horgan
Karina A. Horgan
Mannan from yeast has been demonstrated to limit infection in animals susceptible to gastrointestinal infection, including pigs, poultry and cows, by blocking the mechanism by which gram-negative bacteria adhere to and invade the intestines. EnterotoxigenicEscherichia coli(ETEC) cause post weaning diarrhoea (PWD) which results in poor weight gain and potential death at great economic cost to the farmer. A mannan rich fraction (MRF) was assessedin vitrofor its impact on ETEC infection of HT-29 intestinal cell line. Gene expression markers for inflammation (TNFαandIL-1β) and TLR4 (TICAM-1andLY96) associated recognition of bacteria were significantly elevated following exposure toE. colialone, but not in combination with MRF compared to the control. HT-29 cells exposed to MRF alone demonstrated significantly reduced expression of immune signalling genesIRAK1,IRF7andJUNwhen compared to the control. HT-29 cell protein abundance for TNFα and TLR4 associated proteins were significantly increased in response toE. coliexposure alone while no significant change was observed for MRF treatment withE. coliinfection.E. coliadhesion to HT-29 cells was significantly decreased with addition of MRF compared toE. coliinfection alone. The action of MRF demonstrated its potential capacity to limit infection on anin vitrolevel through blocking bacterial interaction with the intestines that leads to infection as marked by a reduction in proinflammatory responses. MRF on its own demonstrated potential anti-inflammatory effects on intestinal cells with the reduction of proinflammatory responses observed.

12 January 2024 in Animals
Verified
Journal Article
Open access
PDF file
NBNiall Browne
Niall Browne
KHKarina Horgan
Karina Horgan
In piglets, it is observed that early weaning can lead to poor weight gain due to an underdeveloped gastrointestinal (GI) tract, which is unsuitable for an efficient absorption of nutrients. Short-chain fatty acids (SCFAs) such as butyrate have demonstrated their ability to improve intestinal development by increasing cell proliferation, which is vital during this transition period when the small and large intestinal tracts are rapidly growing. Previous reports on butyrate inclusion in feed demonstrated significantly increased feed intakes (FIs) and average daily gains (ADGs) during piglet weaning. Similar benefits in piglet performance have been observed with the inclusion of yeast cell wall in diets. A proprietary mix of yeast cell wall, SCFAs, and zinc proteinate (YSM) was assessed here in vitro to determine its impact on cellular growth, metabolism and appetite-associated hormones in ex vivo small intestinal pig cells and STC-1 mouse intestinal neuroendocrine cells. Intestinal cells demonstrated greater cell densities with the addition of YSM (150 ppm) compared to the control and butyrate (150 ppm) at 24 h. This coincided with the higher utilisation of both protein and glucose from the media of intestinal cells receiving YSM. Ghrelin (an appetite-inducing hormone) demonstrated elevated levels in the YSM-treated cells on a protein and gene expression level compared to the cells receiving butyrate and the control, while satiety hormone peptide YY protein levels were lower in the cells receiving YSM compared to the control and butyrate-treated cells across each time point. Higher levels of ghrelin and lower PYY secretion in cells receiving YSM may drive the uptake of protein and glucose, which is potentially facilitated by elevated gene transporters for protein and glucose. Greater ghrelin levels observed with the inclusion of YSM may contribute to higher cell densities that could support pig performance to a greater extent than butyrate alone.

17 April 2023 in Porcine Health Management
Verified
Journal Article
Open access
PDF file
NBNiall Browne
Niall Browne
DDDaniel Daly
Daniel Daly
KHKarina Horgan
Karina Horgan
Background: In swine intestinal barrier deterioration can be caused by exposure to harmful bacteria, toxins or contaminants that can lead to a leaky gut and post weaning diarrhoea. A leaky gut leads to increased infection, inflammation and poor nutrient absorption that can impair piglet growth and ultimately survival. Application of yeast cell wall (YCW) products may offer an opportunity to reduce the intestinal barrier damage caused by microbial challenge. A Mannan rich fraction (MRF) and three YCW products were compared by examining their impact on intestinal barrier function using a Jejunal model of intestine in response to a bacterial challenge using Salmonella LPS. Results: Trans epithelial electrical resistance (TEER) readings showed MRF had a significantly higher barrier function (P ≤ 0.05) over the positive control while YCW products A, B and C demonstrated no significant improvement to the positive control. Transcriptome analysis of the IPEC-J2 cells showed that differentially expressed genes associated with the gene ontology (GO) term for Structural molecule activity was significantly upregulated in the MRF treated cells over the positive control cells with 56 genes upregulated compared to product B (50 genes), Product C, (25 genes) and the negative control’s 60 genes. Product A had no functional grouping under the structural molecule activity term. Both qPCR and western blotting analysis of tight junction associated genes showed that MRF treated cells demonstrated significantly higher Claudin 3 junctional gene expression (P ≤ 0.05) over the positive control and treatments A, B and C. Occludin expression was significantly higher in MRF treated cells (P ≤ 0.05) over the positive control and product B. A nonsignificant rise in TJP-1 gene expression was observed in the MRF treated cells when compared to the positive control. Protein abundances of Claudin 3, Occludin and TJP-1 were significantly (P ≤ 0.05) higher following MRF application to LPS challenged IPEC-J2 cells over the positive control. Conclusions: The difference in each YCW products production and composition appeared to influence intestinal barrier integrity. The action of MRF demonstrates its potential ability to raise intestinal barrier integrity of IPEC-J2 intestinal cells on an in vitro level through significantly elevated intracellular connections.

25 February 2025 in Journal of Applied Animal Nutrition
Verified
Journal Article
Open access
PDF file
NBNiall Browne
Niall Browne
AMA. McCormack
A. McCormack
KHKarina Horgan
Karina Horgan
Yeast cell wall (YCW) prebiotics from Saccharomyces cerevisiae, can be added to the diet of animals as an effective decoy molecule for Gram negative bacteria, helping to prevent colonisation of the gut by disease-causing organisms. However, the form and processing of YCW can affect its efficacy in preventing attachment of pathogens to the gut wall and, hence, colonisation. Several commercial yeast cell wall products, A, B and C, including a mannan rich fraction (MRF) product, were assessed for their ability to interfere with the attachment of Salmonella spp. to intestinal IPEC-J2 cells. Attachment of three serovars S. enterica Enteritidis, S. enterica Heidelberg, and S. enterica Typhimurium to IPEC-J2 cells was consistently inhibited with addition of MRF and, to a lesser extent, products B and C, while product A resulted in a greater attachment compared to the control. The reduced attachment of the three Salmonella spp. serovars to IPEC-J2 cells in the presence of MRF coincided with lower gene expression and protein of inflammatory markers interleukin (IL)-1β, IL-8 and tumour necrosis factor α. However, products B and C had a more limited impact. Inversely IPEC-J2 cells in the presence of product A demonstrated higher inflammatory gene expression likely as a consequence of higher Salmonella attachment rates. This is important regarding gut health and function, as inflammation is implicated in poor performance and health. The use of MRF and, to a lesser extent, products B and C provided a means to limit the proliferation of foodborne strains of Salmonella spp. found in pig intestinal cells.